Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
0.4813
-0.0351 (-6.80%)
At close: May 22, 2026, 4:00 PM EDT
0.4670
-0.0143 (-2.97%)
After-hours: May 22, 2026, 7:59 PM EDT

Sunshine Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-6.04-5.98-5.13-4.51-26.74-12.44
Depreciation & Amortization
0.340.330.220.150.030.01
Stock-Based Compensation
--0.01--0.92
Other Adjustments
1.141.96-0.34-18.329.79
Change in Receivables
-1.15-0.12-2.34-0.59-0.52-0.01
Changes in Inventories
-0.99-1.64-6.01-2.370.04-0.08
Changes in Accounts Payable
-0.16-0.193.98-1.363.36-0.02
Changes in Accrued Expenses
-----0.050.02
Changes in Income Taxes Payable
0.04--0.81-0.070.24-
Changes in Other Operating Activities
0.310.29-2.11-0.020.08-0.03
Operating Cash Flow
-5.71-5.33-12.52-8.78-5.25-1.83
Capital Expenditures
-0.17-0.17-1.66-0.08-0.19-
Purchases of Intangible Assets
-0.56-0.66-0.32-0.71-0.11-
Payments for Business Acquisitions
-----14.35-
Other Investing Activities
0.05--0.130.03-
Investing Cash Flow
-0.76-0.84-1.98-0.66-14.62-
Long-Term Debt Issued
-----3.32
Long-Term Debt Repaid
-----1.9-0.48
Net Long-Term Debt Issued (Repaid)
-----1.92.84
Issuance of Common Stock
3.484.7512.084.0943.56-
Repurchase of Common Stock
---3.14-0.54-0.1-
Net Common Stock Issued (Repurchased)
3.484.758.943.5543.46-
Other Financing Activities
-0.04---0.13-2.10.06
Financing Cash Flow
4.414.758.943.4339.472.9
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.660.86-1.040.470.18-0.02
Net Cash Flow
-1.29-1.42-5.56-6.0119.61.08
Free Cash Flow
-5.88-5.51-14.18-8.86-5.44-1.83
FCF Margin
-16.57%-15.16%-40.67%-36.76%-125.24%-800.75%
Free Cash Flow Per Share
-1.25-1.32-20.21-690.63-717.00-1400.52
Levered Free Cash Flow
-6.66-7.35-11.51-8.26-25.14-9.68
Unlevered Free Cash Flow
-6.83-7.63-11.94-9-23.73-2.53
Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q